123 related articles for article (PubMed ID: 32693120)
1. Toll-like 4 receptor (TLR4) expression on peripheral blood mononuclear cells in renal transplant recipients with pre-transplant chronic interstitial nephritis indicates patients at risk of graft deterioration.
Zmonarski SC; Banasik M; Golebiowski T; Madziarska K; Mazanowska O; Myszka M; Zmonarska J; Letachowicz K; Dawiskiba T; Krajewska M
Transpl Immunol; 2020 Oct; 62():101319. PubMed ID: 32693120
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like 4 Receptor Expression on Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Can Help to Indicate the Risk of Graft Deterioration in Patients Who Experienced an Episode of Symptomatic Cytomegalovirus Infection.
Zmonarski SC; Banasik M; Gołębiowski T; Letachowicz K; Madziarska K; Żabińska M; Zmonarska J; Mazanowska O; Krajewska M
Transplant Proc; 2020 Oct; 52(8):2394-2402. PubMed ID: 32444127
[TBL] [Abstract][Full Text] [Related]
3. Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?
Zmonarski SC; Madziarska K; Golebiowski T; Banasik M; Mazanowska O; Madziarski M; Krajewska M
Transpl Immunol; 2019 Apr; 53():43-50. PubMed ID: 30592973
[TBL] [Abstract][Full Text] [Related]
4. Expression of PBMC TLR4 in Renal Graft Recipients Who Experienced Delayed Graft Function Reflects Dynamic Balance Between Blood and Tissue Compartments and Helps Select a Problematic Patient.
Zmonarski S; Madziarska K; Banasik M; Mazanowska O; Magott-Procelewska M; Hap K; Krajewska M
Transplant Proc; 2018; 50(6):1744-1749. PubMed ID: 30056893
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the rate of progression of chronic renal transplant rejection using the proliferating cell nuclear antigen ].
Simić-Ogrizović S; Starcević-Bozović A; Blagojević R; Radivojević D; Djkanović L
Srp Arh Celok Lek; 2002; 130(5-6):159-64. PubMed ID: 12395435
[TBL] [Abstract][Full Text] [Related]
6. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
[TBL] [Abstract][Full Text] [Related]
7. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
Chang HR; Lin CC; Lian JD
Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
[TBL] [Abstract][Full Text] [Related]
8. Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence.
Zmonarski SC; Kościelska-Kasprzak K; Banasik M; Myszka M; Żabińska M; Madziarska K; Mazanowska O; Krajewska M; Boratyńska M; Klinger M
Transplant Proc; 2016 Jun; 48(5):1519-25. PubMed ID: 27496439
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
11. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
[TBL] [Abstract][Full Text] [Related]
12. TLR-2, TLR-4 and MyD88 genes expression in renal transplant acute and chronic rejections.
Sharbafi MH; Assadiasl S; Pour-Reza-Gholi F; Barzegari S; Mohammadi Torbati P; Samavat S; Nicknam MH; Amirzargar A
Int J Immunogenet; 2019 Dec; 46(6):427-436. PubMed ID: 31286693
[TBL] [Abstract][Full Text] [Related]
13. MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function.
Lenihan CR; O'Kelly P; Mohan P; Little D; Walshe JJ; Kieran NE; Conlon PJ
Ren Fail; 2008; 30(4):345-52. PubMed ID: 18569905
[TBL] [Abstract][Full Text] [Related]
14. Risk and outcome of pyelonephritis among renal transplant recipients.
Graversen ME; Dalgaard LS; Jensen-Fangel S; Jespersen B; Østergaard L; Søgaard OS
BMC Infect Dis; 2016 Jun; 16():264. PubMed ID: 27287058
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.
Liu LS; Li J; Chen XT; Zhang HX; Fu Q; Wang HY; Xiong YY; Liu S; Liu XM; Li JL; Huang M; Wang CX
Int J Clin Pract Suppl; 2015 May; (183):43-52. PubMed ID: 26177348
[TBL] [Abstract][Full Text] [Related]
16. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.
Braudeau C; Ashton-Chess J; Giral M; Dugast E; Louis S; Pallier A; Braud C; Moreau A; Renaudin K; Soulillou JP; Brouard S
Transplantation; 2008 Jul; 86(1):130-6. PubMed ID: 18622290
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression of Toll-Like Receptors 2 and 4 in Renal Transplant Rejection.
Heidari M; Ebadi P; Abbasi S; Afshari A; Yaghobi R; Salehipour M; Karimi MH
Exp Clin Transplant; 2020 Dec; 18(7):757-762. PubMed ID: 32799786
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease in kidney transplant recipients-is it different from chronic native kidney disease?
Udayaraj UP; Casula A; Ansell D; Dudley CR; Ravanan R
Transplantation; 2010 Oct; 90(7):765-70. PubMed ID: 20686443
[TBL] [Abstract][Full Text] [Related]
19. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
[TBL] [Abstract][Full Text] [Related]
20. Impact of Subclinical Rejection on Kidney Graft Function.
Tugmen C; Sert I; Kebapci E; Tasli F; Karadeniz T; Avci EK; Tuncer K; Ayna TK; Tanrisev M; Olmez M; Karaca C
Transplant Proc; 2019 Dec; 51(10):3304-3308. PubMed ID: 31732212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
